Figure 1.
Comparison of 5-year recurrence-free survival among GGO-predominant tumors. GGO, ground glass opacity; NoMLE, no mediastinal lymph node evaluation; MLS, mediastinal lymph node sampling; MLND, mediastinal lymph node dissection.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.